Tompkins Financial Corp Abb Vie Inc. Transaction History

Tompkins Financial Corp

$1.04 Billion
Q3 2024

A detailed history of Tompkins Financial Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Tompkins Financial Corp holds 33,771 shares of ABBV stock, worth $6.08 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares

33,771

Previous 36,625 7.79%

Holding current value

$6.08 Million

Previous $6.28 Million 6.18%

% of portfolio

0.64%

Previous 0.66%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$163.84 - $199.33 $467,599 - $568,887	-2,854 Reduced 7.79%	33,771 $6.67 Million
Q2 2024 Jul 17, 2024	SELL	$154.79 - $180.76 $12,228 - $14,280	-79 Reduced 0.22%	36,625 $6.28 Million
Q1 2024 Apr 08, 2024	SELL	$159.82 - $182.1 $72,718 - $82,855	-455 Reduced 1.22%	36,704 $6.68 Million
Q4 2023 Jan 08, 2024	BUY	$137.6 - $154.97 $523,980 - $590,125	3,808 Added 11.42%	37,159 $5.76 Million
Q3 2023 Nov 20, 2023	SELL	$133.59 - $154.65 $5,210 - $6,031	-39 Reduced 0.12%	33,351 $4.97 Million
Q2 2023 Jul 12, 2023	SELL	$132.51 - $164.9 $129,727 - $161,437	-979 Reduced 2.85%	33,390 $4.5 Million
Q1 2023 Apr 20, 2023	SELL	$144.61 - $166.54 $14,027 - $16,154	-97 Reduced 0.28%	34,369 $5.48 Million
Q4 2022 Jan 06, 2023	SELL	$138.31 - $165.87 $25,449 - $30,520	-184 Reduced 0.53%	34,466 $5.57 Million
Q3 2022 Oct 13, 2022	BUY	$134.21 - $153.93 $41,470 - $47,564	309 Added 0.9%	34,650 $4.65 Million
Q2 2022 Jul 14, 2022	SELL	$137.62 - $174.96 $168,446 - $214,151	-1,224 Reduced 3.44%	34,341 $5.26 Million
Q1 2022 May 12, 2022	BUY	$131.98 - $163.75 $3.54 Million - $4.39 Million	26,832 Added 307.25%	35,565 $5.77 Million
Q4 2021 Jan 24, 2022	SELL	$107.43 - $135.93 $35,881 - $45,400	-334 Reduced 3.68%	8,733 $1.18 Million
Q3 2021 Oct 22, 2021	SELL	$106.4 - $120.78 $50,433 - $57,249	-474 Reduced 4.97%	9,067 $978,000
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $4.24 Million - $5.72 Million	-52,623 Reduced 84.65%	9,541 $1.02 Million
Q4 2020 Feb 05, 2021	BUY	$80.49 - $108.67 $4.21 Million - $5.68 Million	52,308 Added 530.72%	62,164 $4.74 Million
Q3 2020 Oct 23, 2020	SELL	$85.91 - $100.83 $49,999 - $58,683	-582 Reduced 5.58%	9,856 $863,000
Q2 2020 Jul 29, 2020	BUY	$73.37 - $98.18 $30,375 - $40,646	414 Added 4.13%	10,438 $1.03 Million
Q1 2020 Apr 22, 2020	SELL	$64.5 - $97.79 $75,787 - $114,903	-1,175 Reduced 10.49%	10,024 $764,000
Q4 2019 Jan 22, 2020	SELL	$72.13 - $90.25 $72,130 - $90,250	-1,000 Reduced 8.2%	11,199 $992,000
Q3 2019 Oct 17, 2019	SELL	$62.98 - $75.72 $154,867 - $186,195	-2,459 Reduced 16.78%	12,199 $924,000
Q2 2019 Jul 17, 2019	SELL	$65.7 - $83.98 $111,427 - $142,430	-1,696 Reduced 10.37%	14,658 $1.07 Million
Q1 2019 Apr 30, 2019	BUY	$77.14 - $90.79 $31,241 - $36,769	405 Added 2.54%	16,354 $1.32 Million
Q1 2019 Apr 17, 2019	BUY	$77.14 - $90.79 $50,295 - $59,195	652 Added 4.26%	15,949 $1.51 Million
Q4 2018 Jan 22, 2019	SELL	$77.85 - $96.01 $50,758 - $62,598	-652 Reduced 4.09%	15,297 $1.41 Million
Q3 2018 Oct 18, 2018	SELL	$88.91 - $98.84 $36,186 - $40,227	-407 Reduced 2.49%	15,949 $1.51 Million
Q2 2018 Jul 18, 2018	BUY	$89.78 - $106.23 $86,458 - $102,299	963 Added 6.26%	16,356 $1.52 Million
Q1 2018 Apr 26, 2018	BUY	$92.01 - $123.21 $418,645 - $560,605	4,550 Added 41.96%	15,393 $1.46 Million
Q4 2017 Jan 24, 2018	SELL	$89.56 - $98.21 $1.84 Million - $2.02 Million	-20,540 Reduced 65.45%	10,843 $1.05 Million
Q3 2017 Oct 17, 2017	BUY	$69.85 - $89.22 $2.19 Million - $2.8 Million	31,383	31,383 $2.79 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tompkins Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Tompkins Financial Corp with notifications on news.

Account

Tompkins Financial Corp Abb Vie Inc. Transaction History